| 中文名 | VGX-1027 |
|---|---|
| 英文名 | 2-(3-phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid |
| 中文别名 |
3-苯基-2-异恶唑啉-5-乙酸
2-(3-苯基-4,5-二氢异恶唑-5-基)乙酸 VGX-1027(GIT-27),免疫调节剂 |
| 英文别名 |
VGX-1027(GIT 27)
VGX 1027 3-Phenyl-2-isoxazoline-5-acetic acid GIT 27 2-(3-PHENYL-4,5-DIHYDROISOXAZOL-5-YL)ACETIC ACID 3-phenyl-4,5-dihydro-5-isoxazoleacetic acid VGX-1027 (Git-27), T4 inhibitior (3-Phenyl-4,5-dihydro-1,2-oxazol-5-yl)acetic acid 5-Isoxazoleacetic acid, 4,5-dihydro-3-phenyl VGX-1027, >= GIT27; GIT27; GIT-27; VGX1027; VGX 3-Phenyl-2-isoxazoline-5-acetic acid 4,5-Dihydro-3-phenyl-5-isoxazoleaceticacid VGX-1027, 10 mM in DMSO VGX-1027 2-Isoxazoline-5-acetic acid, 3-phenyl VGX-1027, 6-0 4,5-DIHYDRO-3-PHENYL-5-ISOXAZOLEACETIC ACID VGX-1027,Tumor Necrosis Factor Rector,inhibit,Interleukin Related,GIT27,GIT-27,Inhibitor,TNF Rector,TNFR VGX-127 (S,R)-3-Phenyl-4,5-dihydro-5-isoxasole acetic acid |
| 描述 | VGX-1027(GIT27)具有免疫调节活性,能降低小鼠巨噬细胞的IL-1β,TNF-α和IL-10分泌。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 沸点 | 381.4±34.0 °C at 760 mmHg |
| 熔点 | 159 °C |
| 分子式 | C11H11NO3 |
| 分子量 | 205.210 |
| 闪点 | 184.5±25.7 °C |
| 精确质量 | 205.073898 |
| PSA | 58.89000 |
| LogP | 1.16 |
| 外观性状 | 固体;White to Orange to Green powder to crystal |
| 蒸汽压 | 0.0±0.9 mmHg at 25°C |
| 折射率 | 1.601 |
| 储存条件 | 0-10°C;存放于惰性气体之中;避免空气,加热 |
|
~%
6501-72-0 |
| 文献:GANIAL IMMUNOTHERAPEUTICS INC. Patent: WO2006/97273 A1, 2006 ; Location in patent: Page/Page column 13 ; |
|
~%
6501-72-0 |
| 文献:Eichinger, Karl; Wokurek, Michael; Zauner, Bernd; Rostami, Mohammad Reza Synthetic Communications, 1997 , vol. 27, # 16 p. 2733 - 2742 |
|
~%
6501-72-0 |
| 文献:Stosic-Grujicic, Stanislava; Cvetkovic, Ivana; Mangano, Katia; Fresta, Massimo; Maksimovic-Ivanic, Danijela; Harhaji, Ljubica; Popadic, Dusan; Momcilovic, Miljana; Miljkovic, Djordje; Kim, Joseph; Al Abed, Yousef; Nicoletti, Ferdinando Journal of Pharmacology and Experimental Therapeutics, 2007 , vol. 320, # 3 p. 1038 - 1049 |